Press Release: 9/11/2025

More Than Capital: The Power of Connection at the MassBio Align Summit

 



SEP 11, 2025



 



By Jason Cordeiro, Chief Operating and Innovation Officer, MassBio



This article was originally posted on Jason Cordeiro’s LinkedIn. 





Why Align Matters Now



Biotech is at a crossroads. With venture capital pullbacks, IPOs stalled, and M&A slowing, early-stage companies face some of the toughest market conditions in over a decade. But breakthrough science isn’t slowing down—it’s waiting for the right partnerships to bring it forward.



That’s where the MassBio Align Summit comes in. On October 7, 2025, in Boston, Align convenes investors, business development leaders, and founders for one purpose: to connect capital, strategy, and science in ways that strengthen the entire biotech ecosystem.



Qualified funders can request complimentary registration, and emerging startups receive discounted access. Register here.



What Makes Align Different



This isn’t just another pitch event. Align is curated for high-intent engagement—every presenting company, every panel, and every conversation is designed to move the industry forward.




  • 50+ cutting-edge companies (Seed to Series B) will present across (check them out):


    • AI/ML-driven drug design, discovery & developmentNext-generation multispecific therapeutics




    • Precision therapeutics



  • Candid industry insights from experts on:

    • The competitive global landscape (including China’s impact)




    • Key investment trends identified by McKinsey




    • Strategies for unlocking innovation through regional ecosystems



  • Unfiltered conversations about the realities of deal flow, licensing, and partnerships in today’s uncertain markets.

  • Targeted one-on-one partnering meetings scheduled through the conference app



Why This Moment Matters



Our 2025 Industry Snapshot showed the challenges clearly:




  • VC dollars flowing to Massachusetts biotechs declined 17% in the first half of 2025.

  • Funding is consolidating at the top, leaving emerging startups squeezed.

  • Acquisitions of Massachusetts companies have slowed significantly.



But Align isn’t about dwelling on headwinds—it’s about facing uncertainty with boldness. By bringing together funders, strategics, and founders in one room, Align creates the relationships and insights that help science break through, even when markets falter.



The Value of Align



At Align, founders aren’t just presenting slides. They’re engaging with potential partners, advisors, and champions who understand the long game of translating discovery into impact.



Each interaction is designed for outcomes:




  • High-quality meetings between attendees

  • Panels with direct, unvarnished perspectives

  • A curated review process ensuring the most promising startups are front and center



Be Part of the Conversation



The pressures on biotech aren’t going away anytime soon. But neither is the potential for breakthrough science. Align is where we come together as a community to see what’s next—and commit to moving it forward.



📅 MassBio Align Summit

October 7, 2025 | Boston Marriott Copley Place



🔗 Learn more and secure your spot: Register here.